top of page

Latest News

Add a general description of the items listed below. You can introduce the list and include any relevant information you want to share. Double click to edit the text.

02/25/2025

Humanwell Pharmaceutical US Receives FDA Clearance to Advance Novel Analgesic RFUS-250 into Phase 1 Clinical Trials

Humanwell Pharmaceutical US, Inc. has received an official letter from the U.S. Food and Drug Administration (FDA), confirming the completion of the agency’s safety review for the clinical protocol submitted under the Investigational New Drug (IND) application for RFUS-250.

DSC04642.JPG
bottom of page